To include your compound in the COVID-19 Resource Center, submit it here.

Rucaparib: Phase II data

Clovis said it stopped enrollment in the open-label, U.S. and Israeli Phase II RUCAPANC trial of oral rucaparib in patients with locally advanced

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE